A Kuhnian Perspective of the Suppression of Scientific Inquiry and its Relationship to Medicinal Properties of Cannabinoids

A Kuhnian Perspective of the Suppression of Scientific Inquiry and its Relationship to Medicinal Properties of Cannabinoids

Loading document ...
Page
of
Loading page ...

Author(s)

Author(s): David A. Dawson

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.2098 24 51 144-146 Volume 8 - Jun 2019

Abstract

Throughout human history societal constraints have been imposed on the areas of inquiry researchers are permitted to pursue, as well as their ability to share newly attained knowledge. American bureaucracy dictates that decisions regarding the suppression of scientific inquiry fall under the dominion of politicians. The political decision to prohibit research of the medicinal potential of phytocannabinoids has resulted in a paradigm Thomas Kuhn would have considered to be in a state of crisis, and the worldview to which cannabinoid scientists have been mandated to adhere with respect to medicinal properties of synthetic and biologic cannabinoids is currently experiencing revolutionary challenges.

References

  1. Bald, M. (2011). Literature suppressed on religious grounds. New York, NY: Facts on File. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=edsbvb&AN=edsbvb.BV040272657&site=eds-live
  2. Bergman, J. (2015). Copernicus, Heliocentricity, and the Catholic Church: What Really Happened. Creation Research Society Quarterly, 51(3), 201–206. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=a9h&AN=102049275&site=eds-live
  3. Centers for Disease Control (April 24, 2018) Synthetic cannabinoids: What are they? What are their effects? National Center for Environmental Health Retrieved from https://www.cdc.gov/nceh/hsb/chemicals/sc/default.html
  4. Dawson D.A. (2018) Synthetic cannabinoids, organic cannabinoids, the endocannabinoid system, and their relationship to obesity, diabetes, and depression. Journal of Molecular Biology 7: 219. doi: 10.4172/2168-9547.1000219
  5. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., … Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (New York, N.Y.), 258(5090), 1946–1949. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=mdc&AN=1470919&site=eds-live
  6. Drug Enforcement Administration. (2017). Schedules of controlled substances: Placement of FDA-approved products of oral solutions containing Dronabinol-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in schedule II Federal Register Retrieved from https://www.federalregister.gov/documents/2017/11/22/2017-25275/schedules-of-controlled-substances-placement-of-fda-approved-products-of-oral-solutions-containing
  7. Drug Enforcement Administration (4/10/2017) Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order. (2017). Federal Register, 82(67), 17119–17124. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=mdc&AN=28425681&site=eds-live
  8. Kuhn, T. S. (2003). The Copernican revolution: planetary astronomy in the development of Western thought. Cambridge, Mass.: Harvard Univ. Press. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=edsbvb&AN=edsbvb.BV036578755&site=eds-live
  9. Kuhn, T. S. (1996). The structure of scientific revolutions, 3rd ed. Chicago, IL: University of Chicago Press. https://doi-org.proxy1.ncu.edu/10.7208/chicago/9780226458106.001.000
  10. Leveillee, N.P. (2011) “Copernicus, Galileo, and the Church: Science in a Religious World.” Inquiries Journal/Student Pulse, 3(05). Retrieved from http://www.inquiriesjournal.com/articles/1675/copernicus-galileo-and-the-church-science-in-a-religious-world
  11. Mechoulam, R. (1973). Marijuana: Chemistry, pharmacology, metabolism and clinical effects. Oxford: Academic Press. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=psyh&AN=1974-04626-000&site=eds-live
  12. Pertwee, R. G. (2006). Cannabinoid pharmacology: the first 66 years. British Journal of Pharmacology, 147 Suppl 1, S163–S171. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=mdc&AN=16402100&site=eds-live
  13. Wood, T. B., Spivey, W. T. N., & Easterfield, T. H. (1899). III.―Cannabinol. Part I. Journal of the Chemical Society, Transactions, 75, 20. Retrieved from https://search-ebscohost-com.proxy1.ncu.edu/login.aspx?direct=true&db=edb&AN=78995642&site=eds-live

Cite this Article:

  • BibTex
  • RIS
  • APA
  • Harvard
  • IEEE
  • MLA
  • Vancouver
  • Chicago

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue June 2019

Volume 8, June 2019


Table of Contents


Order Print Copy

World-wide Delivery is FREE

Share this Issue with Friends:


Submit your Paper